source
- Eli Lilly to acquire AtaiBeckley in up to $3.8 billion deal, entering psychedelics marketEli Lilly announced it will buy AtaiBeckley, offering $6.75 per share for the company’s common stock. The transaction includes an upfront commitment of about $2.8 billion and a contingent value rig…
- Biopharma layoffs may exceed 14,000 jobs in H1 as Takeda, BioNTech and Viatris cut staffBiopharma firms are preparing for a wave of job cuts in the first half of 2026, with total layoffs projected to affect more than 14,000 employees, according to data compiled by BioSpace. The bulk…